Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalloproteinases inhibitors

Details for Australian Patent Application No. 2005268765 (hide)

Owner Protera S.R.L.

Inventors Fragai, Marco; Luchinat, Claudio; Venturi, Chiara; Lo Conte, Mauro; Bertini, Ivano; Nativi, Cristina

Agent Fisher Adams Kelly

Pub. Number AU-B-2005268765

PCT Pub. Number WO2006/013193

Priority FI2004A000174 03.08.04 IT

Filing date 29 July 2005

Wipo publication date 9 February 2006

Acceptance publication date 4 August 2011

International Classifications

C07C 317/14 (2006.01) Sulfones

A61K 31/10 (2006.01)

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07H 3/02 (2006.01) Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms

Event Publications

22 March 2007 PCT application entered the National Phase

  PCT publication WO2006/013193 Priority application(s): WO2006/013193

3 September 2009 Assignment before Grant

  Abiogen Pharma S.p.A. The application has been assigned to Protera S.R.L.

4 August 2011 Application Accepted

  Published as AU-B-2005268765

1 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005268767-5-substituted 1H-pyrrolo[3,2-B]pyridines

2005268761-Device for transmitting a torque